ReviewJournal of oncology practice2016
Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer.
Review in Journal of oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.
- Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021Pooled it
- Online-based interventions for sexual health among individuals with cancer: a systematic review.BMC health services research · 2018Pooled it
- Quercetin alleviates radiation-induced erectile dysfunction by modulating oxidative stress and apoptosis through the Nrf2/HO-1 pathway.European journal of medical research · 2026Article
- L-arginine attenuates cisplatin-induced sexual dysfunction in male Wistar rats by modulating circulating testosterone and NO/cGMP signaling.JBRA assisted reproduction · 2026Article
- Sexual health in older adults with hematologic malignancies - a sub-analysis of a Danish cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Sexual Dysfunction and Sexual Distress Among Patients With Lymphoma: A Cross-Sectional Study.Oncology nursing forum · 2025Article
- Research progress on sexual functioning and associated factors in childhood cancer survivors: a scoping review.EClinicalMedicine · 2024Article
- Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus.Nature reviews. Gastroenterology & hepatology · 2024Review
- The erectile and ejaculatory implications of the surgical management of rectal cancer.International journal of urology : official journal of the Japanese Urological Association · 2023Review
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.Genes & diseases · 2023Review
- Beet leaf (beta vulgaris L.) extract attenuates iron-induced testicular toxicity: Experimental and computational approach.Heliyon · 2023Article
- Sexual and fertility-related adverse effects of medicinal treatment for cancer; a national evaluation among medical oncologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Erectile dysfunction among testicular cancer survivors: A systematic review and meta-analysis.Heliyon · 2021Article
- Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy.Current urology reports · 2021Review
- Erectile dysfunction and cancer: current perspective.Radiation oncology journal · 2020Article
- Men's health clinics: a real need or a marketing strategy.International journal of impotence research · 2020Review
- Oncofertility in adult and pediatric populations: options and barriers.Translational andrology and urology · 2020Review
- Sexual dysfunction and male infertility.Nature reviews. Urology · 2018Review
- Penile prosthesis in the management of erectile dysfunction following cancer therapy.Translational andrology and urology · 2017Review
- Managing Erectile Dysfunction After Cancer: More Than Penile Rigidity.Journal of oncology practice · 2016Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer can cause sexual adverse effects by direct and indirect pathways. It can involve sexual organs, indirectly affect body image, or cause fatigue or depression with subsequent effects on libido. Erectile dysfunction (ED), the inability to obtain or maintain an erection firm enough for sexual intercourse, can also result from adverse effects of cancer treatment, such as fatigue, pain, or anxiety about therapy. In addition, depressed feelings about having cancer can affect sexuality, causing a range of signs and symptoms that can lead to ED. Chemotherapy, hormone therapy, surgery, and radiation can all cause sexual adverse effects. Additional factors that play a role include patient age and degree of ED before starting cancer treatment. In this article, we discuss how chemotherapy, hormone therapy, surgery, and radiation affect erectile function as well as possible treatment options for ED.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.